Skip to main content

Month: February 2020

FTAI Reports Record Fourth Quarter and Full Year 2019 Results, Dividend of $0.33 per Common Share

NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (NYSE:FTAI) (the “Company” or “FTAI”) today reported financial results for the quarter and full year ended December 31, 2019. The Company’s consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release.Financial OverviewFor the fourth quarter of 2019, total FAD was $288.6 million. This amount includes $174.2 million from our aviation leasing portfolio, and $167.2 million from our infrastructure business, offset by $(52.8) million from corporate and other.Joe Adams, FTAI’s CEO, stated, “Our fourth quarter was exceptional, as was all of 2019.  2020 is setting up to be even better.”Fourth Quarter 2019 DividendsOn February 27, 2020, the Company’s Board of Directors (the “Board”)...

Continue reading

Flushing Financial Corporation Announces Receipt of Empire Shareholder Approval for Pending Acquisition of Empire Bancorp, Inc. and Election Deadline of April 1, 2020 for Merger Consideration

UNIONDALE, N.Y., Feb. 27, 2020 (GLOBE NEWSWIRE) — Flushing Financial Corporation (Nasdaq: FFIC) (“Flushing”), parent company of Flushing Bank, announced today that at the special shareholders meeting of Empire Bancorp, Inc. (“Empire”), held today, the merger of Empire with and into Flushing (the “merger”) pursuant to the Agreement and Plan of Merger, dated October 24, 2019, as amended (the “merger agreement”) was approved by the shareholders of Empire. As previously announced, the required regulatory approvals for the merger have been obtained. Flushing and Empire expect the merger to close effective on or about April 4, 2020.John R. Buran, President and CEO of Flushing, stated, “We are pleased that the Empire shareholders have provided approval to continue to move forward on our acquisition of Empire. We are excited about the projected...

Continue reading

Festi hf.: Ársuppgjör 2019

Helstu niðurstöðurFramlegð af vöru- og þjónustusölu á fjórða ársfjórðungi (4F) 2019 5.372 m.kr. samanborið við 4.858 á sama tímabili 2018 og hækka um 10,6%Rekstrarkostnaður á fjórða ársfjórðungi (4F) 2019 3.606 m.kr. samanborið við 3.329 á sama tímabili 2018 og hækkar um 8,3%EBITDA Festi að undanskildum kostnaði við kaup á Hlekk nam 1.766 m.kr. á 4F 2019 samanborið við 1.529 m.kr. á 4F 2018 sem er 15,5% hækkun á milli ára.EBITDA að undanskildum kostnaði við kaup á Hlekk nam 7.743 m.kr. árið 2019 samanborið við 4.958 m.kr. árið 2018 sem skýrist af mestu að því að ELKO, Krónan, Bakkinn og Festi fasteignir voru hluti af samstæðu Festi 4 mánuði 2018, en allt árið 2019.Vaxtaberandi skuldir námu 33.380 m.kr. í árslok 2019 en voru 37.314 m.kr. í árslok 2018.Hreinar vaxtaberandi skuldir námu 28.011 m.kr. í árslok 2019 en voru 33.047 m.kr. í árslok...

Continue reading

Exxe Group Inc. Announces Appointment of John Lowy as Securities Counsel

NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) — Exxe Group, Inc. (OTC PINK: AXXA), a diversified company focused on synergistic acquisitions in real estate, sustainable technology, media, financial services and agribusiness, announced today that venerable corporate/securities attorney and investment banker John B. Lowy has joined Exxe Group, Inc. as securities counsel. In his role as securities counsel, Mr. Lowy will advise AXXA with respect to its ongoing public disclosures and filings, and will provide ongoing strategic corporate and legal advice. Going forward, AXXA believes that Mr. Lowy’s decades of legal and capital markets experience will aid in executing management’s corporate goals and vision.John Lowy is the founder and senior partner of John B. Lowy, P.C., based in New York City. John is a highly-respected and acknowledged...

Continue reading

Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has entered into definitive agreements with several institutional investors for the issuance and sale of 4,000,000 shares of its common stock and warrants to purchase up to 2,000,000 shares of its common stock, at a combined purchase price of $2.50 per share and associated warrant, for aggregate gross proceeds of $10.0 million, in a registered direct offering priced at-the-market under Nasdaq rules.H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.The warrants will have an exercise price of $2.50 per share and exercise period commencing immediately upon issuance...

Continue reading

Sprott Inc. Declares Fourth Quarter 2019 Dividend

TORONTO, Feb. 27, 2020 (GLOBE NEWSWIRE) — Sprott Inc. (“Sprott” or the “Company”) (TSX:SII) today declared an eligible dividend of $0.03 per common share for the quarter ended December 31, 2019, payable on March 24, 2020 to shareholders of record at the close of business on March 9, 2020.About SprottSprott is an alternative asset manager and a global leader in precious metal and real asset investments. Through its subsidiaries in Canada, the US and Asia, Sprott is dedicated to providing investors with specialized investment strategies that include Exchange Listed Products, Lending, Managed Equities and Brokerage. Sprott’s common shares are listed on the Toronto Stock Exchange under the symbol (TSX:SII). For more information, please visit www.sprott.com.Investor contact information:Glen WilliamsManaging Director(416) 943-4394gwi...

Continue reading

Sorrento Therapeutics Presents Interim Positive Results of Phase 1b Resiniferatoxin (RTX) in Cancer Pain Trial

Fourteen subjects with advanced cancer pain received epidural RTX (04 to 15 ug)Most common treatment-related adverse event was transient post-procedure related painThree subjects at the higher doses had rapid and marked pain reduction after treatmentOne additional cohort was added to further evaluate a 25 ug dose for upcoming Phase 3 studiesSAN DIEGO, Feb. 27, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced that an interim analysis of an ongoing Phase 1b study of resiniferatoxin (RTX) administered via epidural route in patients with intractable cancer pain has generated positive data. The study is completing enrollment of an additional 25 ug expansion dose cohort. Based on full study results a dose will be selected for RTX to proceed to Phase 3 pivotal trials in patients with...

Continue reading

Clean TeQ Announces Capital Structure Update

MELBOURNE, Australia, Feb. 27, 2020 (GLOBE NEWSWIRE) — Clean TeQ Holdings Limited (Clean TeQ or Company) (ASX/TSX:CLQ; OTCQX:CTEQF) advises that the following securities have lapsed and have been cancelled:The Company’s current capital structure therefore constitutes of the following class of securities:For more information, please contact:This announcement is authorised for release to the market by the Board of Directors of Clean TeQ Holdings Limited.About Clean TeQ Holdings Limited (ASX/TSX: CLQ) – Based in Melbourne, Australia, Clean TeQ is a global leader in metals recovery and industrial water treatment through the application of its proprietary Clean-iX® continuous ion exchange technology. For more information about Clean TeQ please visit the Company’s website www.cleanteq.com.About the Clean TeQ Sunrise Project – Clean TeQ...

Continue reading

PyroGenesis Announces New Website Launch

MONTREAL, Feb. 27, 2020 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is proud to announce the launch of its redesigned website taking effect this March. The website has been revamped to include new features and improved functionality that provide instant access to essential information and features geared towards PyroGenesis’ interested parties.  PyroGenesis’ new website will be continuously updated with business developments, events, company presentations, media mentions and press releases. Once launched, visitors are encouraged...

Continue reading

Dorchester Minerals, L.P. Announces 2019 Results

DALLAS, Feb. 27, 2020 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership’s net income for the year ended December 31, 2019 of $52,765,000, or $1.50 per common unit.A comparison of the Partnership’s consolidated results for the twelve month periods ended December 31, 2019 and 2018 are set forth below:The Partnership’s independent engineering consultants estimated its total proved oil and natural gas reserves to be 103.7 billion cubic feet of natural gas equivalents (bcfe) as of December 31, 2019.  Approximately 25% of these reserves are attributable to the Partnership’s Net Profits Interests and 75% are attributable to its Royalty Properties.  Natural gas accounted for 44% of proved reserves as of December 31, 2019, all of which were classified as proved developed producing.The...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.